- N/T
Triall TRL
Nous manquons de données de trading précises.
Cela peut être attribué à plusieurs raisons, y compris une liquidité limitée sur les échanges ou une radiation. Ou peut-être en raison de l'incapacité de fournir un support pour les échanges où cet actif est actuellement négocié.
Capitalisation boursière
$82,570.19Rang #--FDV
--Rang #--Investisseurs
Abonnés Twitter
Performance Twitter
153WeakClassement par Twitter #9829- 0
- 100
- 500
- 1000
- 1500
À propos TRL
Triall is a company that provides innovative software and services to clinical researchers and patients involved in clinical trials. Clinical trials are research studies that evaluate the safety and effectiveness of new treatments before they can be approved for use in the market.
What makes Triall unique?
Triall is unique compared to other cryptocurrencies because it is specifically designed for the healthcare and clinical trial industry. It offers a platform-native means of payment for software and services related to clinical trials. This focus on the healthcare sector sets Triall apart from other cryptocurrencies that may have a broader range of applications. Additionally, Triall's token, TRL, is a key building block for its future vision of a self-sustaining digital ecosystem where data resources can be exchanged fairly and securely between patients, clinical trial sponsors, and service providers. This emphasis on creating a secure and equitable exchange of data resources further distinguishes Triall from other cryptocurrencies.